An osteoconductive PLGA scaffold with bioactive β-TCP and anti-inflammatory Mg(OH)2 to improve: In vivo bone regeneration

Eun Jin Go, Eun Young Kang, Seul Ki Lee, Sookhyun Park, Jae Hwa Kim, Wooram Park, Ik Hwan Kim, Bogyu Choi, Dong Keun Han

Research output: Contribution to journalArticlepeer-review

58 Citations (Scopus)


Poly(lactic-co-glycolic acid) (PLGA) has been widely used as a biomaterial for pharmaceutical and medical applications. However, the decomposition products of PLGA are known to acidify the surrounding tissue of the implanted site, causing an inflammatory response. Previously, we developed PLGA/inorganic nanocomposites and optimized the amounts of inorganic compounds, β-tricalcium phosphate (β-TCP) and magnesium hydroxide [Mg(OH)2], in terms of osteogenesis of normal human osteoblasts and anti-inflammatory responses of preosteoclastic cells in vitro. In this study, the potential of the optimized PLGA/β-TCP/Mg(OH)2 nanocomposite (TCP/MH) to promote bone repair through osteoinductive, osteoconductive, and anti-inflammatory abilities was assessed using a bone defect in a rat humeral defect model. PLGA nanocomposites with or without inorganic compounds, PLGA, β-TCP, MH, and TCP/MH were prepared through one-step bulk modification using a twin-screw extruder. The resulting TCP/MH nanocomposite successfully enhanced the bone regeneration rate for allowing complete bone defect healing with significantly suppressed inflammatory responses. Taken together, the organic and inorganic bioactive nanocomposite developed in this study, TCP/MH, is a promising material in orthopedic implantation.

Original languageEnglish
Pages (from-to)937-948
Number of pages12
JournalBiomaterials Science
Issue number3
Publication statusPublished - 2020 Feb 20
Externally publishedYes

Bibliographical note

Funding Information:
This work was supported by the Basic Science Research Program (2017R1A2B3011121) and Bio & Medical Technology Development Program (2018M3A9E2024579) through the National Research Foundation of Korea funded by the Ministry of Science and ICT (MSIT), a grant of the Korea Health Technology R&D Project (HI18C0089) through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, and Core Materials Technology Development Program (10048019) funded by Ministry of Trade, Industry and Energy (MOTIE), Republic of Korea.

Publisher Copyright:
© The Royal Society of Chemistry 2020.

ASJC Scopus subject areas

  • Biomedical Engineering
  • General Materials Science


Dive into the research topics of 'An osteoconductive PLGA scaffold with bioactive β-TCP and anti-inflammatory Mg(OH)2 to improve: In vivo bone regeneration'. Together they form a unique fingerprint.

Cite this